Charleston, SC -- (SBWIRE) -- 12/12/2013 -- otcstockcenter.com, provide information specifically for trades in the micro cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Lets have a look on Few Hot Stocks, adidas AG (ADR)(OTCMKTS:ADDYY), ARCAM AB ORD(OTCMKTS:AMAVF), Biozone Pharmaceuticals Inc(OTCBB:BZNE), 3D EYE SOLUTIONS, IN(OTCMKTS:TDEY)
Shares of adidas AG (ADR)(OTCMKTS:ADDYY) traded in a range of $60.37 to $60.75, completing the day up +0.28% to $60.46. The total volume of shares exchanged was 44,311.00. The day started out with an opening price of $60.75 versus prior close of $60.29. The company has the total of 418.43 million outstanding shares while its market capitalization is now about $25.23 billion. adidas AG, together with its subsidiaries, engages in designing, developing, producing, and marketing of athletic and sports lifestyle products worldwide. It offers footwear, apparel, and hardware, such as bags and balls primarily under the adidas and Reebok brands.
What was the Moving Force behind ADDYY On Bullish Run? Read This Research Report on ADDYY
With the latest decline of -5.79%, ARCAM AB ORD(OTCMKTS:AMAVF) now has YTD performance 421.67% which for the week is negative at -7.34%. The total number of shares traded on the latest trading day was about 14,036.00 shares, and changed hands at price range of $140.00 to $145.00 apiece. The company ended previous trading at $149.50. Arcam AB provides additive manufacturing solutions for the production of metal components.
Has AMAVF Found The Bottom And Ready To Gain Momentum? Find Out Here
Biozone Pharmaceuticals Inc(OTCBB:BZNE) finished last trade at $0.540, losing -8.47%. Trading volume recorded for this company was about 445,778.00 shares as compared to its average volume of 944,857.00 shares. The share price plunged almost -21.17% in the last one month while its 52 week high is $3.75. The company has the total of 69.61 million outstanding shares while its market capitalization is now about $37.59 million. Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally.
Why Should Investors Buy BZNE After the Recent Fall? Just Go Here and Find Out
3D EYE SOLUTIONS, IN(OTCMKTS:TDEY) closed latest trading day at $0.0037, down -2.63%, on volume of over 25.45 million shares. The stock fell -26% in the last 5 days. Its average trading volume is 30.49 million shares. In the time frame of the last one month, the share-price has dropped almost -70.4%. Its market capitalization was $1.13 million. 3D Eye Solutions, Inc. engages in developing, providing, and integrating content conversion service for the 3D stereo and auto-stereo media industry in the United States.
Will TDEY Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Center
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)